Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Foghorn Therapeutics Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K/A10-KS-1/A
Net income  -108.9-101.3-68.8-51.1-26.3
Depreciation and amortization  3.33.21.30.70.4
Stock-based compensation  14.38.43.01.70.7
Change in working capital   [+]2.71.0-1.02.42.5
Other operating activities  282.138.534.20.00.1
Cash from operations  193.6-50.3-31.3-46.3-22.6
   
Capital expenditures   [+]-1.2-3.3-16.2-1.0-1.5
Purchases of short-term investments, net  -243.139.5-93.0  
Cash from investing  -244.336.2-108.9-1.0-1.5
   
Issuance of common stock, net   42.2122.1  
Option exercises  1.81.41.20.7 
Other cash from financing  3.5-18.496.624.751.8
Cash from financing  1.822.4217.524.051.8
   
Free cash flow  192.4-53.6-47.5-47.3-24.2
        Per share (diluted)  $4.63($1.44)($4.30)($11.28)($8.21)
   
Cash paid for interest   1.70.70.4 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy